|
Jul 16
|
Jefferies Reiterates a Buy Rating on LivaNova PLC (LIVN) With a $79 PT
|
|
Jul 9
|
LivaNova to Announce Second-Quarter 2025 Results
|
|
Jun 25
|
Are Options Traders Betting on a Big Move in LivaNova Stock?
|
|
Feb 28
|
LivaNova PLC Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
|
|
Feb 26
|
LivaNova Full Year 2024 Earnings: EPS Beats Expectations
|
|
Feb 26
|
LivaNova PLC (LIVN) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ...
|
|
Feb 25
|
LivaNova (LIVN) Tops Q4 Earnings Estimates
|
|
Feb 25
|
LivaNova: Q4 Earnings Snapshot
|
|
Feb 25
|
LivaNova Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Guidance
|
|
Feb 21
|
Getinge’s surgical perfusion market exit ‘opens door’ for LivaNova
|
|
Dec 30
|
5 Beaten-Down MedTech Stocks Set to Rebound in 2025
|
|
Nov 14
|
LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences
|
|
Nov 13
|
Livanova hits sleep apnea trial goals, plans FDA filing
|
|
Nov 13
|
Goldman Sachs Says Improving Growth Could Propel These 2 Stocks Higher
|
|
Nov 12
|
Shareholders Will Be Pleased With The Quality of LivaNova's (NASDAQ:LIVN) Earnings
|
|
Nov 11
|
LivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints
|
|
Sep 25
|
LivaNova to Announce Third-Quarter 2024 Results
|
|
Aug 27
|
Returns At LivaNova (NASDAQ:LIVN) Are On The Way Up
|
|
Jun 18
|
LivaNova to Announce Second-Quarter 2024 Results
|
|
Jun 13
|
An Intrinsic Calculation For LivaNova PLC (NASDAQ:LIVN) Suggests It's 31% Undervalued
|